ArticleACS nano2026
Utilizing Constrained Bicyclic Peptides for
André Shamsabadi, Adam Creamer, Christy J Sadler, Aida Abdelwahed, Katherine U Gaynor, Yuliya Demydchuk, Gabriela Ivanova-Berndt, Katerine Van Rietschoten, Paul Beswick, Liuhong Chen and 6 more
Abstract read
In one paragraphArticle in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
André ShamsabadiDepartment of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Adam CreamerDepartment of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Christy J SadlerDepartment of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0009-0006-2763-7097 Aida AbdelwahedDepartment of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Katherine U GaynorBicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Yuliya DemydchukBicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Gabriela Ivanova-BerndtBicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Katerine Van RietschotenBicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.ORCID 0000-0002-0360-8244 Paul BeswickBicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Aleksei LullaDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.
Molly M StevensDepartment of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0002-7335-266X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Constrained bicyclic peptides (
Indexed as
COVID-19Nucleocapsid ProteinsPeptides, CyclicSARS-CoV-2Biosensing TechniquesEnzyme-Linked Immunosorbent AssayHumansImmunoassayNucleocapsid ProteinsPeptides, Cyclicantibody mimicbicyclic peptidesdiagnosticsELISALFIA
Identifiers
PMID41685809
PMCPMC12947737
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390